Loading clinical trials...
Loading clinical trials...
A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Subcutaneous Abatacept in Adults With Active Primary Sjögrens Syndrome
Conditions
Interventions
Abatacept
Placebo
Locations
71
United States
St. Jude Hospital Yorba Linda
Fullerton, California, United States
Riverside Medical Clinic
Riverside, California, United States
Colorado Arthritis Associates
Lakewood, Colorado, United States
North Georgia Rheumatology Group
Lawrenceville, Georgia, United States
Intermountain Research Center Inc.
Boise, Idaho, United States
Johns Hopkins University
Baltimore, Maryland, United States
Start Date
December 6, 2016
Primary Completion Date
August 7, 2018
Completion Date
July 23, 2019
Last Updated
August 10, 2020
NCT06991114
NCT07229144
Lead Sponsor
Bristol-Myers Squibb
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions